Remodeling of Bone Marrow Niches and Roles of Exosomes in Leukemia.

Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium: Internet ISSN: 1422-0067 (Electronic) Linking ISSN: 14220067 NLM ISO Abbreviation: Int J Mol Sci Subsets: MEDLINE

Original Publication: Basel, Switzerland : MDPI, [2000-

Cell Communication* ; Tumor Microenvironment*; Bone Marrow/*metabolism ; Exosomes/*metabolism ; Leukemia/*metabolism; Bone Marrow/pathology ; Exosomes/pathology ; Humans ; Leukemia/pathology

Leukemia is a hematological malignancy that originates from hematopoietic stem cells in the bone marrow. Significant progress has made in understanding its pathogensis and in establishing chemotherapy and hematopoietic stem cell transplantation therapy (HSCT). However, while the successive development of new therapies, such as molecular-targeted therapy and immunotherapy, have resulted in remarkable advances, the fact remains that some patients still cannot be saved, and resistance to treatment and relapse are still problems that need to be solved in leukemia patients. The bone marrow (BM) niche is a microenvironment that includes hematopoietic stem cells and their supporting cells. Leukemia cells interact with bone marrow niches and modulate them, not only inducing molecular and functional changes but also switching to niches favored by leukemia cells. The latter are closely associated with leukemia progression, suppression of normal hematopoiesis, and chemotherapy resistance, which is precisely the area of ongoing study. Exosomes play an important role in cell-to-cell communication, not only with cells in close proximity but also with those more distant due to the nature of exosomal circulation via body fluids. In leukemia, exosomes play important roles in leukemogenesis, disease progression, and organ invasion, and their usefulness in the diagnosis and treatment of leukemia has recently been reported. The interaction between leukemia cell-derived exosomes and the BM microenvironment has received particular attention. Their interaction is believed to play a very important role; in addition to their diagnostic value, exosomes could serve as a marker for monitoring treatment efficacy and as an aid in overcoming drug resistance, among the many problems in leukemia patients that have yet to be overcome. In this paper, we will review bone marrow niches in leukemia, findings on leukemia-derived exosomes, and exosome-induced changes in bone marrow niches.

Nat Med. 2009 Mar;15(3):300-5. (PMID: 19234461)
Cancer Res. 2015 Jun 1;75(11):2222-31. (PMID: 25791383)
J Cancer Res Clin Oncol. 2018 May;144(5):945-954. (PMID: 29468438)
Theranostics. 2019 Jul 28;9(19):5642-5656. (PMID: 31534508)
Br J Haematol. 2007 May;137(4):288-96. (PMID: 17456052)
Blood Adv. 2018 Mar 13;2(5):509-515. (PMID: 29500219)
J Immunol. 2015 Mar 15;194(6):2919-29. (PMID: 25662994)
Mol Cancer. 2014 Jul 11;13:169. (PMID: 25015105)
Leukemia. 2018 Mar;32(3):575-587. (PMID: 28816238)
Nat Rev Immunol. 2002 Aug;2(8):569-79. (PMID: 12154376)
Semin Cancer Biol. 2015 Dec;35 Suppl:S185-S198. (PMID: 25818339)
Blood. 2016 Jul 14;128(2):253-64. (PMID: 27257182)
Cell Stem Cell. 2015 Mar 5;16(3):254-67. (PMID: 25748932)
Mol Biol Rep. 2018 Dec;45(6):2491-2499. (PMID: 30350234)
Blood. 2000 Jan 1;95(1):309-13. (PMID: 10607717)
Nat Commun. 2018 Feb 6;9(1):519. (PMID: 29410432)
Am J Hematol. 2019 Mar;94(3):346-357. (PMID: 30394563)
Int J Mol Med. 2019 Dec;44(6):2133-2144. (PMID: 31638195)
Stem Cells Int. 2018 May 27;2018:9863194. (PMID: 29977309)
Br J Haematol. 2019 Oct;187(1):e11-e15. (PMID: 31388999)
EMBO Rep. 2019 Jul;20(7):e47546. (PMID: 31267709)
Nature. 1973 Jun 1;243(5405):290-3. (PMID: 4126434)
Oncogene. 2020 Feb;39(6):1198-1212. (PMID: 31649334)
Blood. 2014 Oct 30;124(18):2834-46. (PMID: 25139351)
Blood. 2010 Dec 2;116(23):4815-28. (PMID: 20713966)
Cell Stem Cell. 2014 Sep 4;15(3):365-375. (PMID: 25017722)
Nat Med. 2003 Sep;9(9):1158-65. (PMID: 12897778)
Leukemia. 2014 Oct;28(10):1978-1987. (PMID: 24637335)
Haematologica. 2011 Nov;96(11):1627-35. (PMID: 21828124)
Int J Cancer. 2012 May 1;130(9):2033-43. (PMID: 21630268)
Nat Med. 2009 Mar;15(3):306-12. (PMID: 19234463)
Proc Natl Acad Sci U S A. 2013 Aug 13;110(33):13576-81. (PMID: 23901108)
J Clin Invest. 2020 Jun 1;130(6):3038-3050. (PMID: 32364536)
Nature. 2014 Jan 16;505(7483):327-34. (PMID: 24429631)
Front Immunol. 2014 Apr 10;5:160. (PMID: 24782865)
Cell. 2016 Mar 10;164(6):1226-1232. (PMID: 26967288)
Bone Marrow Res. 2014;2014:128436. (PMID: 24822129)
Leukemia. 2009 Dec;23(12):2233-41. (PMID: 19727127)
J Clin Invest. 2013 Sep;123(9):3876-88. (PMID: 23979164)
Leuk Res. 2018 Jan;64:52-60. (PMID: 29190514)
Biochim Biophys Acta Rev Cancer. 2017 Aug;1868(1):183-198. (PMID: 28363872)
Cancers (Basel). 2019 Jan 17;11(1):. (PMID: 30658425)
Blood. 2010 Feb 18;115(7):1433-43. (PMID: 20007544)
Cell Rep. 2016 Aug 30;16(9):2428-41. (PMID: 27545880)
Curr Hematol Malig Rep. 2015 Jun;10(2):96-103. (PMID: 25921386)
Blood Cells. 1978;4(1-2):7-25. (PMID: 747780)
Nat Med. 2018 May;24(4):450-462. (PMID: 29505034)
Acta Haematol. 2020;143(2):112-117. (PMID: 31288222)
Leuk Lymphoma. 2014 Aug;55(8):1715-24. (PMID: 24251864)
Nat Med. 2008 Mar;14(3):325-30. (PMID: 18278053)
Curr Opin Hematol. 2016 May;23(3):268-73. (PMID: 26866730)
Leukemia. 2015 May;29(5):999-1003. (PMID: 25652737)
Biol Cell. 2002 Nov;94(7-8):493-500. (PMID: 12566222)
Proc Natl Acad Sci U S A. 2020 Sep 29;117(39):24326-24335. (PMID: 32929022)
Lancet Oncol. 2010 Nov;11(11):1029-35. (PMID: 20965785)
Blood. 2012 Sep 6;120(10):2032-41. (PMID: 22493293)
J Hematol Oncol. 2020 Mar 28;13(1):25. (PMID: 32222150)
Nat Cell Biol. 2017 Aug;19(8):891-903. (PMID: 28714970)
Nat Cell Biol. 2007 Jun;9(6):654-9. (PMID: 17486113)
Cell Mol Life Sci. 2017 Feb;74(4):579-590. (PMID: 27436341)
Angiogenesis. 2012 Mar;15(1):33-45. (PMID: 22203239)
Nature. 2014 Feb 20;506(7488):328-33. (PMID: 24522528)
Nat Commun. 2018 Sep 21;9(1):3846. (PMID: 30242148)
J Exp Med. 2014 Sep 22;211(10):1925-35. (PMID: 25180064)
J Clin Invest. 2017 Jun 30;127(7):2815-2828. (PMID: 28530640)
Cell Rep. 2013 Sep 26;4(6):1131-43. (PMID: 24055056)
Drug Discov Today. 2016 Sep;21(9):1464-1471. (PMID: 27130156)
Blood. 2016 May 19;127(20):2391-405. (PMID: 27069254)
N Engl J Med. 2015 Sep 17;373(12):1136-52. (PMID: 26376137)
N Engl J Med. 2001 Apr 5;344(14):1038-42. (PMID: 11287973)
Leukemia. 2008 May;22(5):941-50. (PMID: 18305549)
Leukemia. 2015 Dec;29(12):2285-95. (PMID: 26108689)
Am J Hematol. 2020 Jun;95(6):691-709. (PMID: 32239758)
Proteomics. 2014 Mar;14(4-5):412-25. (PMID: 24339442)
Nature. 2017 May 4;545(7652):98-102. (PMID: 28445461)
Trends Immunol. 2011 Jul;32(7):315-20. (PMID: 21531624)
Proc Natl Acad Sci U S A. 2013 Oct 15;110(42):17005-10. (PMID: 24089451)
Clin Cancer Res. 2008 May 1;14(9):2519-26. (PMID: 18451212)
Blood. 2010 Feb 4;115(5):957-64. (PMID: 19897586)
Am J Hematol. 2016 Jul;91(7):742-6. (PMID: 27059166)
Nat Cell Biol. 2017 Mar;19(3):214-223. (PMID: 28218906)
Cell Stem Cell. 2019 May 2;24(5):769-784.e6. (PMID: 30905620)
Blood. 2016 Nov 3;128(18):2253-2257. (PMID: 27574191)
Cell Mol Life Sci. 2015 Jan;72(1):1-10. (PMID: 25156068)
Nature. 2009 Jul 9;460(7252):259-63. (PMID: 19516257)
Cell Stem Cell. 2018 Jan 4;22(1):64-77.e6. (PMID: 29276143)
Nat Cell Biol. 2017 Nov;19(11):1336-1347. (PMID: 29035359)
Science. 2009 May 15;324(5929):895-9. (PMID: 19443776)
Oncogene. 2013 May 30;32(22):2747-55. (PMID: 22797057)
Blood. 2009 Aug 6;114(6):1150-7. (PMID: 19401558)
J Leukoc Biol. 2019 Apr;105(4):741-753. (PMID: 30702754)
Nat Rev Rheumatol. 2016 Mar;12(3):154-68. (PMID: 26607387)
Blood. 2017 Mar 9;129(10):1320-1332. (PMID: 28049638)
J Immunol. 2001 Jun 15;166(12):7309-18. (PMID: 11390481)
Curr Mol Biol Rep. 2017 Jun;3(2):53-62. (PMID: 29098141)
J Immunol. 2010 Nov 1;185(9):5268-78. (PMID: 20881190)
Cell. 2006 Jan 27;124(2):407-21. (PMID: 16439213)
Hematology. 2018 Dec;23(10):729-739. (PMID: 29902132)
Immunity. 2006 Dec;25(6):977-88. (PMID: 17174120)

19KK0224 Japan Society for the Promotion of Science; 19K07479 Japan Society for the Promotion of Science; 19K09392 Japan Society for the Promotion of Science; 18H02622 Japan Society for the Promotion of Science

Keywords: bone marrow niches; exosomes; leukemia

Date Created: 20210306 Date Completed: 20210415 Latest Revision: 20210415

20240829

PMC7918833

10.3390/ijms22041881

33668652